We should take some of the most replicated findings in #MECFS and study them in #longCOVID patients. Some of these findings, if also present in #longCOVID, *could* potentially imply avenues for symptom management or therapeutic treatment.
Here are a few that might be interesting:
1️⃣Low serum carnitine: https://me-pedia.org/wiki/Carnitine 
2️⃣ Low natural killer cell function: https://me-pedia.org/wiki/Natural_killer_cell
3️⃣ Elevated lactate (blood, brain): https://me-pedia.org/wiki/Lactic_acid
4️⃣ Cerebral hypoperfusion: https://me-pedia.org/wiki/Brain#Blood_flow
12. Elevated IgA (corresponds to illness severity): https://me-pedia.org/wiki/Immunoglobulin_A
13. Low red blood cell magnesium: https://me-pedia.org/wiki/Magnesium 
14. Impaired pyruvate dehydrogenase expression: https://me-pedia.org/wiki/Pyruvate_dehydrogenase
15. Increased glycolysis (anaerobic respiration): https://me-pedia.org/wiki/Glycolysis#Glycolysis_and_myalgic_encephalomyelitis
There is so much more than this. Here is a partial list: https://me-pedia.org/wiki/List_of_abnormal_findings_in_chronic_fatigue_syndrome_and_myalgic_encephalomyelitis (many findings aren’t even on MEpedia yet, let alone this page—but anyone can contribute, so have a go!)
I want to underline the importance of #longCOVID researchers doing thorough reviews of the #MECFS, #POTS, #EDS, #MCAS, #fibromyalgia and #PTLD literatures so they can cite relevant research and compare and contrast their findings, embedding them within 50+ years of context.
I also want to underline the history of 75+ outbreaks ( https://me-pedia.org/wiki/Epidemic_myalgic_encephalomyelitis), which resulted in a % of those infected developing the attached symptoms, many of which should look...awfully familiar to anyone who has #longCOVID or treats people who do.
As well as the importance of recognizing the many possible comorbidities and overlapping syndromes that #longCOVID patients may be developing or are at risk for. https://me-pedia.org/wiki/Comorbidities_of_Myalgic_Encephalomyelitis
Here’s how I think about this in the context of #MECFS: https://twitter.com/jenbrea/status/1352675184038166529?s=20
Here’s how I think about this in the context of #longCOVID (as well as #MECFS): https://twitter.com/jenbrea/status/1353372183456702467?s=20
Almost completely unstudied in #MECFS, but I believe of eminent importance, are mast cells ( https://me-pedia.org/wiki/Mast_cell ) and connective tissue ( https://me-pedia.org/wiki/Collagen ).

I think they help explain the “multi hit” hypothesis of #MECFS, which should be a hypothesis in #longCOVID, too.
Finally, it is estimated that 50% of #MECFS patients meet criteria for #hEDS or #HSD, https://me-pedia.org/wiki/Ehlers-Danlos_syndrome#ME.2FCFS

Enough physicians are seeing connective tissue disease in #longCOVID, there’s a new ICD code for it: https://twitter.com/AlisonSbrana/status/1350273115285147650?s=20
Inflammatory connective tissue damage, at multiple sites, causing a dizzying array of possible pathologies unique to each patient, that some patients *will ‘spontaneously’ heal from with time, but others will not, with an overlay of #MCAS, might just be was pathogens can do...
If you got to the end, congrats!! What are other major findings/areas of inquiry in #MECFS #POTS #EDS #MCAS #fibro #PTLD that you think #longCOVID researchers and clinicians should know about?
...and copy in some cool folks in research & medicine. Please share with any colleagues who might be interested. I think engaging with this literature is so important. @evolutionarypsy @ahandvanish @YoniFreedhoff @ScottGottliebMD @ShannonOMac @Dr2NisreenAlwan @trishgreenhalgh
Do any of these findings surprise you?
You can follow @jenbrea.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.